Patents by Inventor Florian Ludwig

Florian Ludwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9931431
    Abstract: Implantable medical devices fabricated from branched polymers are disclosed.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: April 3, 2018
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, David C. Gale, Bin Huang, Mikael O. Trollsas, Thierry Glauser, Florian Ludwig
  • Patent number: 9744259
    Abstract: Stent scaffolds comprising branched biocompatible polymers are disclosed.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: August 29, 2017
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, David C. Gale, Bin Huang, Mikael O. Trollsas, Thierry Glauser, Florian Ludwig
  • Patent number: 9561351
    Abstract: An implantable medical device is disclosed having a helical construct including a set of spiral coils for local in vivo application of a therapeutic substance in a biological lumen. The helical construct is configured to apply less than 0.75 Bar of pressure to the biological lumen wall. The helical construct can have at least two sets of spiral coils having opposing helical directions. The device can be used for the treatment of vascular disorders such as restenosis and vulnerable plaque.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: February 7, 2017
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Klaus Kleine, David C. Gale, Fozan El-Nounou, Syed F. A. Hossainy, Florian Ludwig
  • Patent number: 9173890
    Abstract: A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.
    Type: Grant
    Filed: November 27, 2007
    Date of Patent: November 3, 2015
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Katsuyuki Murase, Jinping Wan, John Stankus, Dariush Davalian, Florian Ludwig
  • Patent number: 9144509
    Abstract: Devices for delivering drugs or other treatment agents locally to the vasculature of a mammal are disclosed. These devices have several related structures and are designed to deliver the drugs to facilitate rapid mixing with the blood flowing past the devices.
    Type: Grant
    Filed: October 12, 2010
    Date of Patent: September 29, 2015
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Paul M. Consigny, David C. Gale, Florian Ludwig, Randolpf von Oepen, Fozan O. El-Nounou, Pamela A. Kramer-Brown, Travis R. Yribarren, William E. Webler, Jr.
  • Patent number: 8709472
    Abstract: Compositions that contain bioactive agent-loaded nanoparticles with heart targeting capabilities and methods of using the same for the treatment of disease are disclosed.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: April 29, 2014
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Katsuyuki Murase, Florian Ludwig, Dariush Davalian
  • Publication number: 20140081417
    Abstract: Stent scaffolds comprising branched biocompatible polymers are disclosed.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 20, 2014
    Applicant: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, David C. Gale, Bin Huang, Mikael O. Trollsas, Thierry Glauser, Florian Ludwig
  • Publication number: 20140046006
    Abstract: Implantable medical devices fabricated from branched polymers are disclosed.
    Type: Application
    Filed: July 12, 2013
    Publication date: February 13, 2014
    Applicant: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, David C. Gale, Bin Huang, Mikael O. Trollsas, Thierry Glauser, Florian Ludwig
  • Patent number: 8486135
    Abstract: This invention relates to implantable medical devices, such as stents, fabricated from hyperbranched-like polymers, comb-like polymers, star polymers, dendrimer-like star polymers, dendrimers, and mixtures thereof.
    Type: Grant
    Filed: April 9, 2007
    Date of Patent: July 16, 2013
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Yunbing Wang, David C. Gale, Bin Huang, Mikael O. Trollsas, Thierry Glauser, Florian Ludwig
  • Patent number: 8388948
    Abstract: The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: March 5, 2013
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Shubhayu Basu, Gene Michal, Florian Ludwig, Jinping Wan, John Stankus
  • Patent number: 8377033
    Abstract: A reinforcement region is formed within the myocardium by introducing a delivery device through a vessel wall to a treatment site within a myocardium. A biomaterial is then delivered to the treatment site as the delivery device is withdrawn from the treatment site to form the reinforcement regions. Formation of the reinforcement region may further include introducing a delivery device through a vessel wall to a region within a myocardium such that the delivery device is positioned within the myocardium substantially parallel to a wall of the myocardium. A biomaterial may be delivered into a space formed within the region by the delivery device. The reinforcement region may be formed around an infarct tissue region of a myocardium to reinforce the damaged tissue.
    Type: Grant
    Filed: September 8, 2010
    Date of Patent: February 19, 2013
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Shubhayu Basu, Randolf von Oepen, Eugene Michal, Florian Ludwig
  • Patent number: 8293226
    Abstract: The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: October 23, 2012
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Shubhayu Basu, Gene Michal, Florian Ludwig, Jinping Wan, John Stankus
  • Publication number: 20120251508
    Abstract: The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 4, 2012
    Applicant: Abbott Cardiovascular Systems Inc.
    Inventors: Shubhayu Basu, Gene Michal, Florian Ludwig, Jinping Wan, John Stankus
  • Publication number: 20120252089
    Abstract: The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 4, 2012
    Applicant: Abbott Cardiovascular Systems Inc.
    Inventors: Shubhayu Basu, Gene Michal, Florian Ludwig, Jingping Wan, John Stankus
  • Patent number: 8252361
    Abstract: Implantable medical devices adapted to erodibly release delivery media for local and regional treatment are disclosed.
    Type: Grant
    Filed: November 28, 2007
    Date of Patent: August 28, 2012
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Pamela A. Kramer-Brown, Florian Ludwig
  • Patent number: 8221744
    Abstract: The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: July 17, 2012
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Shubhayu Basu, Gene Michal, Florian Ludwig, Jinping Wan, John Stankus
  • Publication number: 20120157751
    Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 21, 2012
    Applicant: ADVANCED CARDIOVASCULAR SYSTEMS INC.
    Inventors: Paul Consigny, Gabriel Asongwe, Mary Beth Michaels, Gene Michal, Evgenia Mandrusov, Jeong Lee, Florian Ludwig, John Eric Henckel, Joseph J. Sciacca, Ken Bueche, Richard Todd Thornton, Fidel Albert Urrabazo, Daniel Wiegand
  • Publication number: 20120148668
    Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Applicant: ADVANCED CARDIOVASCULAR SYSTEMS INC.
    Inventors: Paul Consigny, Gabriel Asongwe, Mary Beth Michaels, Gene Michal, Evgenia Mandrusov, Jeong Lee, Florian Ludwig, John Eric Henckel, Joseph J. Sciacca, Ken Bueche, Richard Todd Thornton, Fidel Albert Urrabazo, Daniel Wiegand
  • Publication number: 20120148609
    Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.
    Type: Application
    Filed: February 21, 2012
    Publication date: June 14, 2012
    Applicant: ADVANCED CARDIOVASCULAR SYSTEMS INC.
    Inventors: Paul Consigny, Gabriel Asongwe, Mary Beth Michaels, Gene Michal, Evgenia Mandrusov, Jeong Lee, Florian Ludwig, John Eric Henckel, Joseph J. Sciacca, Ken Bueche, Richard Todd Thornton, Fidel Albert Urrabazo, Daniel Wiegand
  • Publication number: 20120064098
    Abstract: Engraftment of therapeutic cells and agents to a target site in an organism is enhanced by mechanical, chemical and biological methods and systems.
    Type: Application
    Filed: November 17, 2011
    Publication date: March 15, 2012
    Applicant: Advanced Cardiovascular Systems, Inc.
    Inventors: Paul Consigny, Gabriel Asongwe, Mary Beth Michaels, Gene Michal, Evgenia Mandrusov, Jeong Lee, Florian Ludwig, John Eric Henckel, Joseph J. Sciacca, Ken Bueche, Richard Todd Thornton, Fidel Albert Urrabazo, Daniel Wiegand